Cardiovascular health 4
Track 21
| Thursday, October 26, 2023 |
| 2:05 PM - 3:40 PM |
| Meeting Room E3.3 |
Speaker
Miss Natalie Raffoul
Healthcare Programs Manager
National Heart Foundation of Australia
New Australian guideline and risk calculator for assessing and managing cardiovascular disease risk
2:05 PM - 3:40 PMSummary
Cardiovascular disease (CVD) is responsible for significant morbidity and premature mortality in Australia. Risk assessment remains fundamental to the primary prevention of CVD and is utilised by general practitioners (GPs) to target pharmacotherapy to individuals who will benefit most.
For the first time in over a decade, Australia’s Guideline for Assessing and Managing CVD Risk has been updated, incorporating a new CVD risk calculator and updated evidence-based recommendations. The guideline has been developed by the Heart Foundation on behalf of the Australian Chronic Disease Prevention Alliance and with endorsement from the Royal Australian College of General Practitioners (pending at the time of abstract submission). The project has invited extensive consultation and input across nine expert advisory groups consisting of GPs, specialists, epidemiologists and consumers.
This interactive session will facilitate an extended discussion around the key clinical recommendations arising from the guideline, focussing on key changes that should be understood by primary care clinicians. The guideline offers new advice on the target age group for CVD risk assessment, and re-defined risk categories and treatment thresholds. It also introduces the concept of reclassification factors (including mental health, ethnicity and family history) as well as providing specific advice on pregnancy complications and the communication of risk. Specific recommendations, resources and practice points for First Nations peoples have been embedded throughout the guideline.
The guideline is accompanied by a new Australian CVD risk calculator developed through modification and recalibration of the New Zealand PREDICT equation. Best practice patient decision aid strategies have been embedded throughout the calculator to facilitate improved communication of risk, and shared decision making between GPs and their patients.
This session will be presented by members of the guideline Expert Steering Group, followed by a live demonstration of the new CVD risk calculator and opportunity for questions and discussions.
For the first time in over a decade, Australia’s Guideline for Assessing and Managing CVD Risk has been updated, incorporating a new CVD risk calculator and updated evidence-based recommendations. The guideline has been developed by the Heart Foundation on behalf of the Australian Chronic Disease Prevention Alliance and with endorsement from the Royal Australian College of General Practitioners (pending at the time of abstract submission). The project has invited extensive consultation and input across nine expert advisory groups consisting of GPs, specialists, epidemiologists and consumers.
This interactive session will facilitate an extended discussion around the key clinical recommendations arising from the guideline, focussing on key changes that should be understood by primary care clinicians. The guideline offers new advice on the target age group for CVD risk assessment, and re-defined risk categories and treatment thresholds. It also introduces the concept of reclassification factors (including mental health, ethnicity and family history) as well as providing specific advice on pregnancy complications and the communication of risk. Specific recommendations, resources and practice points for First Nations peoples have been embedded throughout the guideline.
The guideline is accompanied by a new Australian CVD risk calculator developed through modification and recalibration of the New Zealand PREDICT equation. Best practice patient decision aid strategies have been embedded throughout the calculator to facilitate improved communication of risk, and shared decision making between GPs and their patients.
This session will be presented by members of the guideline Expert Steering Group, followed by a live demonstration of the new CVD risk calculator and opportunity for questions and discussions.
Takeaways
1. Identify key clinical recommendations relating to the assessment of CVD risk outlined in the new Australian guideline
2. Describe the new Australian CVD risk calculator and understand how it is used in clinical practice
3. Identify key clinical recommendations relating to the management of CVD risk outlined in the new Australian guideline
2. Describe the new Australian CVD risk calculator and understand how it is used in clinical practice
3. Identify key clinical recommendations relating to the management of CVD risk outlined in the new Australian guideline
Biography
Natalie Raffoul is the national Healthcare Programs Manager at the Heart Foundation responsible for overseeing the design, build and delivery of health programs which seek to improve the early detection and management of cardiovascular disease in Australia. She has a background as a cardiology hospital pharmacist and the CVD & Diabetes Clinical Lead at NPS MedicineWise. She has extensive real world implementation science experience, translating clinical evidence and insights on cardiovascular disease and diabetes. Her national implementation programs have contributed to almost 400,000 Australians seeing their GP for a Heart Health Check and have enabled the introduction of innovative digital primary care strategies to support structured CVD risk assessment in Australia.
